Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trilaciclib with concurrent chemoradiotherapy for unresectable stage III squamous non-small cell lung cancer
ChiCTR2500109840Phase 2Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trilaciclib in Pulmonary squamous cell carcinoma, sponsored by West China Hospital of Sichuan University. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
trilaciclib
03
Conditions
Pulmonary squamous cell carcinoma
Beyond the preview
Go deeper on ChiCTR2500109840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109840.